Signatur Biosciences

Signatur Biosciences develops molecular diagnostic kits that condense complex RNA signatures into a single PCR assay. The platform allows standard qPCR machines in hospitals to perform precision diagnostics for cancers and chronic diseases without requiring specialized central laboratories. Their initial focus is on breast cancer prognosis, aiming to reduce turnaround times and costs for clinicians and patients.